Recruiting

High Touch vs. Standard Outreach

Sponsor:

Abramson Cancer Center at Penn Medicine

Code:

NCT07102147

Conditions

Lung Cancer (Diagnosis)

Anxiety

Depression in Adults

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

High Touch Outreach

Study Details

Brief summary:

The goal of this trial is to compare the impact of two outreach strategies (high touch vs. standard outreach) on a collaborative care program delivered via telehealth to patients with lung cancer.

Conditions

Lung Cancer (Diagnosis)

Anxiety

Depression in Adults

Study ID

NCT07102147

Start date

Aug 18, 2025

Status verified date

May, 2026

Completion date

Jun 30, 2027

Anticipated

Primary completion date

Mar 31, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Are aged 18 years or older.
  • Are currently being seen by Penn Medicine Thoracic Oncology for lung cancer treatment or survivorship care.
  • Are referred to collaborative care by a Penn Medicine Thoracic Oncology clinician for treatment of depression, anxiety, or other psycho-therapy services.

Exclusion Criteria:

  • Are already receiving psycho-therapy treatment services outside of Penn Medicine's collaborative care program, Penn Integrated Care (PIC).
  • Have a significant and/or untreated medical and/or psychiatric co-morbidity (e.g., other cancers, schizophrenia, acute suicidal and/or homicidal ideation) that make them ineligible for the Penn CoCM program.

Study Design

Enrollment

30 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: High Touch Outreach

Patients in the high touch outreach arm will receive a gain-framed message via text (preferred modality), MyPennMedicine message, email, and/or postal mail that links to the digital screener; an informational flyer about collaborative care sent via postal mail, the MyPennMedicine portal, email, and/or text; and a direct request from their oncology provider to collaborative care for those patients who have not responded to outreach efforts by their next oncology visit post-referral.

no intervention: Standard Outreach

Patients in the standard outreach arm will receive a standard message sent via text (preferred modality), MyPennMedicine message, email, and/or postal mail that links to the digital screener; this message is one that is similar to that already used in Penn Integrated Care's practice.

Interventions

High Touch Outreach

Gain-framed message, informational flyer, and direct request

Primary outcome measure

  • Reach - Completion of the intake assessment amongst referred patients. [ Time Frame: Measured per patient up to 30 days after randomization. ]

Central Contacts and Locations

Central contacts

Jennifer Steltz, MRA

215-573-2593jennifer.steltz@pennmedicine.upenn.edu

Jocelyn Wainwright, MS

215-615-4226jocelyn.wainwright@pennmedicine.upenn.edu

Locations

Abramson Cancer Center at the University of Pennsylvania

Recruiting

Philadelphia, Pennsylvania, United States, 19104

Contacts

Alexandria Muench, PsyD

215-421-4491amuench@pennmedicine.upenn.edu

More Information

Sponsor

Abramson Cancer Center at Penn Medicine

Last update posted

May 28, 2026

Last verified

May, 2026

Keywords

  • Lung cancer
  • Anxiety
  • Depression
  • Collaborative care

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Abramson Cancer Center at Penn Medicine on 2026-05-28.